Multiple studies have revealed various miRNAs that specifically target the three missing receptors ER, PR, and HER2 as well as the breast cancer susceptibility gene BRCA1 in TNBC development (see Table 1). This evidence concerns the gene BRCA1 and breast carcinoma.